Intramolecular Interactions Encoded in Lipophilicity: Their Nature and Significance

Lipophilicity in Drug Action and Toxicology

Volumn 4, Issue , 2008, Pages 49-71

  Testa, Bernard ^a   Carrupt, Pierre Alain ^a   Guillard, Patrick ^a   Tsai, Ruey Shiuan ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

2D two dimensional; 3D three dimensional; Capacity factor; Molecular volume; Polarity parameter

Indexed keywords

CAPACITY FACTORS; INTRAMOLECULAR INTERACTIONS; LIPOPHILICITY; MOLECULAR VOLUME; POLARITY PARAMETERS;

EID: 84958680788     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527614998.ch4     Document Type: Chapter

References (31)

1. Testa, B., and Kier, L. B., Med. Res. Rev. 11, 35-48 (1991)
2. Carrupt, P. A., El Tayar, N., Karlén, A., and Testa, B., Methods Enzymol. 203, 638-677 (1991)
3. Van de Waterbeemd, H., and Testa, B., The parametrization of lipophilicity and other structural properties in drug design. In: Advances in Drug Research, Vol 16. Testa B. (Ed.). Academic Press: London; 85-225 (1986)
4. El Tayar, N., Tsai, R. S., Testa, B., Carrupt, P. A., and Leo, A., J. Pharm. Sci. 80, 590-598 (1991)
5. El Tayar, N., Testa, B., and Carrupt, P. A., J. Phys. Chem. 96, 1455-1459 (1992)
6. Vallat, P., Gaillard, P., Carrupt, P. A., Tsai, R. S. and Testa, B., Helv. Chim. Acta 78, 471-485 (1995)
7. Rekker, R. F., and De Kort, H. M., Eur. J. Med. Chem. 14, 479-488 (1979)
8. Hansch, C., and Leo, A., Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley: New York 1979
9. Leo, A. J., Chem. Rev. 93, 1281-1306 (1993)
10. Mayer, J. M., van de Waterbeemd, H., and Testa, B., Eur. J. Med. Chem. 17, 17-25 (1982)
11. Tsantili-Kakoulidou, A., El Tayar, N., van de Waterbeemd, H. and Testa, B., J. Chromatogr. 389, 33-45 (1987)
12. Mayer, J. M., Testa, B., van de Waterbeemd, H., and Bornand-Crausaz, A., Eur. J. Med. Chem. 17, 453-459 (1982)
13. Mayer, J. M., Testa, B., van der Waterbeemd, H., and Bornand-Crausaz, A., Eur. J. Med. Chem. 17, 461-466 (1982)
14. Repond, C., Mayer, J. M., van de Waterbeemd, H., Testa, B., and Linert, W., Int. J. Phar-maceut. 38, 47-57 (1987)
15. Takács-Novák, K., Kökési, J., Podányi, B., Noszál, B., Tsai, R. S., Lisa, G., Carrupt, P. A., and Testa, B., Helv. Chim. Acta 78, 553-562 (1995)
16. Testa, B., and Murset-Rossetti, L., Helv. Chim. Acta 61, 2530-2537 (1978)
17. Tsai, R. S., Testa, B., El Tayar, N., and Carrupt, P. A., J. Chem. Soc. Perkins Trans. II, 1797-1802 (1991)
18. El Tayar, N., Mark, A. E., Vallat, P., Brunne, R. M., Testa, B., and van Gunsteren, W. E., J. Med. Chem. 36, 3757-3764 (1993)
19. Hansch, C., and Anderson, S. M., J. Org. Chem. 32, 2583-2586 (1967)
20. Walther, B., Carrupt, P. A., El Tayar, N., and Testa, B., Helv. Chim. Acta 72, 507-517 (1989)
21. Wiley, R. A., and Rich, D. H., Med. Res. Rev. 3, 327-384 (1993)
22. Rich, D. H. Effect of hydrophobic collapse on enzyme-inhibitor interactions. Implications for the design of peptidomimetics. In: Perspectives in Medicinal Chemistry. Testa, B., Kyburz, E., Fuhrer, W., and Giger, R. (Eds.). VCH: Weinheim; 15-25 (1993)
23. Vander Velde, D. G., Georg, G. I., Grunewald, G. L., Gunn, C. W. and Mitscher, L. A., J. Am. Chem. Soc. 115, 11650-11651 (1993)
24. Wittekind, H. H., Testa, B.and Estreicher, J., Helv. Chim. Acta 71, 1228-1234 (1988)
25. Tsai, R. S., Carrupt, P. A., Testa, B., El Tayar, N., Grunewald, G. L. and Casy, A. F., J. Chem. Res. (S) 298-299; (M) 1901-1920 (1993)
26. Hopfinger, A. J., and Battershell, R. D., J. Med. Chem. 19, 569-573 (1976)
27. Parker, G. R., Lemke, T. L., and Moore, E. C., J. Med. Chem. 20, 1221-1225 (1977)
28. Parker, G. R., J. Pharm. Sci. 67, 513-516 (1978)
29. Jiang, X. K., Acc. Chem. Res. 21, 361-367 (1988)
30. Carrupt, P. A., Testa, B., Bechalany, A., El Tayar, N., Descas, P., and Perrissoud, D., J. Med. Chem. 34, 1272-1275 (1991)
31. Gaillard, P., Carrupt, P. A., and Testa, B., Bioorg. Med. Chem. Lett 4, 737-742 (1994)